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In this work, we study the role of phosphoryla-
tion as a regulatory mechanism for the interac-
tion between the E3 ubiquitin ligase ItchWW3
domain and two PPxY motifs of one of its tar-
gets, the Epstein-Barr virus latent membrane
protein 2A. Whereas ligand phosphorylation
only diminishes binding, domain phosphoryla-
tion at residue T30 abrogates it. We show that
two ItchWW domains can be phosphorylated
at this position, using CK2 and PKA kinases
and/or with stimulated T lymphocyte lysates.
To better understand the regulation process,
we determined the NMR structures of the
ItchWW3-PPxY complex and of the phos-
phoT30-ItchWW3 variant. The peptide binds
the domain using both XP and tyrosine grooves.
A hydrogen bond from T30 to the ligand is also
detected. This hydrogen-bond formation is pre-
cluded in the variant, explaining the inhibition
upon phosphorylation. Our results suggest
that phosphorylation at position 30 in ItchWW
domains can be a mechanism to inhibit target
recognition in vivo.
INTRODUCTION
HECT-type E3 ubiquitin ligases participate in the direct
recognition of substrates and, in combination with en-
zymes E1 and E2, catalyze the covalent attachment
of ubiquitin to their target proteins (Fang et al., 2002;
Hershko et al., 2000). The Nedd4 family of ligases is con-
served in evolution from yeast to mammals. They contain
several WW domains, a C2 membrane localization do-
main, and the characteristic HECT (homologous to the
E6-AP C terminus) catalytic domain. The selection of pro-
teins for polyubiquitination often occurs through specificStructure 15,interactions between the WW domains and motifs present
in target proteins (Ingham et al., 2004; Woelk et al., 2006).
The WW domain is a highly abundant structural and func-
tional unit found in a large number of otherwise unrelated
proteins (Bork and Sudol, 1994). The WW domains pres-
ent in E3 ligases mostly belong to group 1. This group is
defined by the ability to target ligands containing a PPxY
motif (Chen and Sudol, 1995; Ingham et al., 2005; Macias
et al., 2002; Staub et al., 1996). In the case of the Itch E3
ligase (also named AIP4), targets include several tran-
scription factors such as JunB, cJun (Fang and Kerppola,
2004), and p75 (Rossi et al., 2005), other E3 ubiquitin li-
gases such as Cbl, Cbl-b, and the related Cbl-c (also
known as Cbl-3) (Courbard et al., 2002; Magnifico et al.,
2003), atrophin, the membrane protein occludin (Traweger
et al., 2002), and the latent membrane protein 2A (LMP2A)
of Epstein-Barr virus (EBV) (Ikeda et al., 2000; Winberg
et al., 2000). With the exception of Cbl ligases, the only se-
quence the remaining targets have in common is the pres-
ence of one or more PPxY motifs. Considering the broad
number of targets bound by Nedd4 proteins as well as
the fact that some targets are recognized by several li-
gases, it seems that each E3 ligase can display either spe-
cialized or redundant recognition, depending on the func-
tional requirements (Ingham et al., 2004; Woelk et al.,
2006). Interestingly, mice homozygous for a loss of func-
tion in the itch gene develop immunological disorders,
suggesting that the Itch protein has at least one nonredun-
dant function (Hustad et al., 1995; Perry et al., 1998).
Structures of Nedd4 and Smurf2 WW domains (other E3
ligases present in mammals) in complex with the binding
region of their targets are available (Chong et al., 2006; Ka-
nelis et al., 2001, 2006). Critical contacts from residues
outside the canonical PPxY motif have been observed in
those complexes, suggesting that WW domains of ubiqui-
tin ligases may require longer motifs than previously
thought. However, sequence comparison of Nedd4 and
Smurf ligands or with those of Itch reveals little in com-
mon outside the central PPxY motif (Figure 1A). We were
thus interested in characterizing the atomic details of
the interaction between ItchWW domains and some473–483, April 2007 ª2007 Elsevier Ltd All rights reserved 473
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Biological Relevance of WW Domain PhosphorylationFigure 1. Schematic Representation of Both Latent Mem-
brane Protein 2A and Itch E3 Ubiquitin Ligase
(A) Different ligands described for the three ubiquitin ligases Itch,
Nedd4, and Smurf2. Sequences were manually aligned to display
the motif they have in common, which is represented surrounded by
a rectangle and in bold characters. Underlined serines are potential
candidates for phosphorylation. Semiconserved glutamic acids pres-
ent in Itch ligands are shown in bold.
(B) Itch constitutive domains arranged in a ‘‘close conformation,’’ as
recently described by Gallagher et al. (2006) (Swissprot accession
number Q8C863). Numbers in the figure were taken from the SMART
database (http://smart.embl-heidelberg.de). C2, protein kinase C con-
served region 2; WW, domain with two conserved Trp (W) residues;
HECT domain, homologous to E6-AP carboxyl terminus. In this confor-
mation, the HECT domain directly contacts the WW domains. Below
are shown the four WW domain sequences of Itch used in this work.
To avoid the unfolding problems of domains 1 and 2 (they are sepa-
rated by a single residue), we expressed a construct containing both
domains, named WW1-2. Residues highlighted in bold or underlined474 Structure 15, 473–483, April 2007 ª2007 Elsevier Ltd All rrepresentative PPxY motifs to be used as a model to de-
scribe how Itch interacts with its ligand partners.
It has recently been observed that Itch becomes phos-
phorylated in cells following T cell activation (Gao et al.,
2004). Indeed, the serine/threonine protein kinase JNK1
phosphorylates Itch in three positions, S199, S323, and
T222 (Gallagher et al., 2006), whereas Fyn does so at tyro-
sine Y371 (Yang et al., 2006). We have previously detected
additional phosphorylation sites in the ItchWW domains
(Figure 1B) (Shaw et al., 2005). Tyrosine phosphorylation
of the viral membrane LMP2A protein has also been de-
scribed (Figure 1C) (Fruehling et al., 1998; Ikeda et al.,
2000; Ingham et al., 2005; Longnecker et al., 2000).
Prompted by these observations, we planned to explore
whether and how a phosphate group may regulate Itch in-
teractions at both the WW domain and ligand level. To do
this, we first determined the solution structure of the first
LMP2A-PPxY motif (named PY peptide; its sequence is
shown in Figure 1D) in complex with the ItchWW3 domain.
We then used nuclear magnetic resonance (NMR) spec-
troscopy to investigate all the possible combinations
between either a wild-type ItchWW3 domain or two syn-
thesized variants of ItchWW3 phosphorylated at positions
S16 and T30 (termed pS16 and pT30, respectively) and
four peptides derived from the two PPxY regions from
LMP2A with and without phosphorylated sites (sequences
are shown in Figure 1D). We also demonstrate the feasibil-
ity of domain phosphorylation at position T30 of ItchWW3
in stimulated and unstimulated lysates of T lymphocytes
and also with two kinases, CK2 and PKA, in vitro.
The conservation of the phosphorylatable hydroxyl-con-
taining residue in many WW domain sequences at the po-
sition equivalent to T30 suggests that this may be one of
the ways in which the interaction of some WW domains
with their ligands is regulated. Phosphorylation as a mech-
anism of regulation has been shown for the Pin1WW
domain, but this occurs at a nonconserved serine. To our
knowledge, our work is the first evidence that there could
be a more general mechanism for WW domain regulation.
RESULTS
Mouse ItchWW Constructs
Of the three Itch constructs prepared, named ItchWW12,
ItchWW3, and ItchWW4, only ItchWW3 and ItchWW4
correspond to either PKA or CK2 predicted phosphorylation sites.
The boxed T residue represents a predicted phosphorylated position
that could not be verified experimentally. T carrying a ˆ or * symbol
means efficiently phosphorylated by CK2 or PKA. The positions are
numbered at the top of the alignment as 16 and 30.
(C) LMP2A protein is represented with 12 transmembrane helices and
both cytoplasmic tails (top). The amino acid sequence corresponding
to the N terminus is displayed, with the phosphorylatable tyrosines
boxed, the Lyn and Syk binding-site regions labeled, and the immuno-
receptor tyrosine-based activation motif (ITAM) circled. Both PPxY
motifs known to interact with Itch are shown in bold. Peptides selected
from the N terminus used in this work are listed (bottom) (Y and S refer,
respectively, to phosphotyrosine and phosphoserine).
(D) Peptide sequences selected from LMP2A used in this work.ights reserved
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Biological Relevance of WW Domain PhosphorylationFigure 2. Interaction between the 15N-Labeled ItchWW3
Domain and the PY Peptide Selected from LMP2A
(A) Overlay of the 1H,15N HSQC spectra of 200 mM 15N-labeled WW
domain in the absence (reference spectrum in black) and presence
of increasing amounts of unlabeled peptide expressed as molar equiv-
alents. Amino acid labels refer to the domain.
(B) Bar representation showing the average chemical-shift changes
observed for each residue at saturation with respect to the free domain
calculated using the equation (ACSD) = [(DdN)
2 + 5(DdH)
2]0.5, whereDdX
are the changes in chemical shift in the 1H and 15N dimensions for each
point in the titration with respect to the reference spectrum.Structure 15,could be expressed in sufficient quantities to obtain struc-
tural information. In ItchWW12 the domains are consecu-
tive, with no linker connecting them. This lack of freedom
may compromise the maintenance of the individual folds
and explain the reduced protein yield. The ItchWW4 se-
quence does not contain the widely conserved second
tryptophan (W32 in ItchWW3). Because the tryptophan is
normally involved in ligand recognition (Macias et al.,
2002), we performed all NMR experiments, including
the structural determination of the complex, using the
ItchWW3 domain (the most canonical of the four), while
all four domains were used for the in vitro phosphorylation
experiments.
Effect of the ItchWW3 Domain on PY Chemical Shifts
The N-terminal cytoplasmic region of EBV LMP2A con-
tains two PPxY motifs (Figure 1C). It has previously been
shown that the first motif binds preferentially to the
ItchWW3 domain, whereas ItchWW12 domains can bind
to both PPxY motifs (Winberg et al., 2000). To investigate
the interaction, we synthesized the PY peptide containing
the first LMP2A-PPxY motif (SNEEPPPPYEDPYWGN)
(top sequence in Figure 1D). This sequence was previ-
ously used to isolate Itch and KIAA0439 as LMP2A-inter-
acting proteins from B cell lysates (Winberg et al., 2000).
We assigned the chemical shifts corresponding to the
PY peptide in both free and bound states and identified
the residues affected upon binding. Only the italicized
residues EPPPPY showed considerable chemical-shift
changes in the presence of the domain. This is in contrast
to other Nedd4 studies, where residues flanking the core
PPxY binding motif have shown a role in determining the
specificity of the interaction with WW domains (Chong
et al., 2006; Kanelis et al., 2001, 2006). The lack of
changes observed at the C terminus of the peptide is in
agreement with a complementary analysis of the binding
of the LMP2A N-terminal domain to the ItchWW3 domain
studied by NMR (Park et al., 2005).
Mapping the Mouse ItchWW3 Binding Site
to the PY Peptide by NMR
We mapped the domain residues involved in binding using
a series of HSQC spectra. Addition of unlabeled PY pep-
tide (Figure 1D) to the 15N-labeled ItchWW3 domain (as-
signment of the free domain is published in Shaw et al.
[2005]) resulted in small backbone amide chemical-shift
changes throughout the whole domain sequence, with
the larger shifts observed for residues in and around
loop 2 (H25, T27, R28) and in the second (V23, N24) and
third b strands (I29, T30, Q31, W32 indol) (Figures 2A
and 2B). Changes in side-chain proton chemical shifts
(C) Isothermal titration calorimetry: 50 mM ItchWW3 in 100 mM NaCl,
50 mM Na phosphate (pH 6.0) was titrated with 0.9 mM SNEEPPP
PYEDPYWGN peptide, prepared in the same buffer. The first of 15 in-
jections had a volume of 10 ml and the remaining injections were 20 ml.
The Origin software (Microcal) was used to interpret the raw calorime-
try data (top panel) and the results are reproduced in the lower panel.473–483, April 2007 ª2007 Elsevier Ltd All rights reserved 475
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Biological Relevance of WW Domain Phosphorylationare observed in the domain as a result of the interaction.
For instance, chemical-shift changes are observed in
both Y21 and W32 aromatic rings. The a proton of R28
also shifts, by more than 1 ppm. The affinity of ItchWW3
to the PY ligand was quantified by isothermal titration cal-
orimetry (ITC) and found to have a dissociation constant
(KD) of 52.1 mM ± 2.14 (Figure 2C). The strength of the in-
teraction lies within the range of KD determined for other
WW domains (3–300 mM) (Macias et al., 1996; Myers
et al., 2001; Pires et al., 2001, 2005; Shi et al., 2002; Ver-
decia et al., 2000).
Structure of ItchWW3 in Complex
with the PY Peptide
In order to determine all the interactions at a molecular
level, we solved the structure of a complex of ItchWW3
and the PY peptide. We maintained the buffer conditions
used in the Kd measurement for determination of the com-
plex structure and a 1:3 protein:peptide ratio. This ratio
corresponds to the last value shown in the titration exper-
iments (Figures 2A and 2B) and was considered to be
a good compromise between chemical-shift changes in-
duced in the domain, detection of intermolecular nuclear
Overhauser effects (NOEs), and artifacts that excess pep-
tide may introduce into the NMR data.
In the complex, the domain folds adopt the characteris-
tic twisted triple-stranded antiparallel b sheet. The com-
parison of the free WW domain structure previously pub-
lished (Shaw et al., 2005) to that of the complex solved
here shows a root-mean-square deviation (rmsd) of
0.55 A˚ when backbone heavy atoms of residues from 10
to 35 are superimposed. The main residues affected
upon ligand binding are in and around the first loop. Be-
cause only some peptide residues show chemical-shift
changes in the presence of the domain, a shorter PY
peptide containing nine residues (10-EEPPPPYED-90) was
used in the calculation of the complex structure. Figure 3A
shows the structure of the complex as a superposition of
the ten best structures obtained in the calculation after
water refinement. As summarized in Table 1, 47 manually
assigned intermolecular NOEs support the calculation of
this complex. The intermolecular NOEs are not equally dis-
tributed along the peptide but rather are concentrated in
the PPPPY fragment, which consequently is the best-de-
fined part of the ligand in the ensemble. For instance, P40
(numbers refer to the nine-residue peptide) shows numer-
ous NOEs to the W32 aromatic ring and to the T30 methyl,
while P50 contacts Y21. Furthermore, Y70 shows NOEs to
the V23 and T30 methyl groups, to the R28 g protons,
and to the a proton of H25. The T30 hydroxyl group is ex-
posed on the surface and oriented toward the ligand, suf-
ficiently close to form a hydrogen bond with the carbonyl of
P50. This hydrogen bond has also been detected in other
complexes (Huang et al., 2000; Pires et al., 2001, 2005).
The last residue in the ligand (D90) is located between the
side chain of E11 and the ring of H25 with which it shows
a pair of weak NOEs, indicating a certain flexibility of the li-
gand at the C terminus. No NOEs were identified from the
domain to the E20 residue, but chemical-shift differences476 Structure 15, 473–483, April 2007 ª2007 Elsevier Ltd All rFigure 3. Solution Structure of ItchWW3 in Complex with the
PY Peptide—10-EEPPPPYED-90
(A) Stereo view of the best-fit backbone (N, Ca, C0) superposition of the
ten lowest-energy structures after water refinement. The backbone is
shown in blue, with selected side chains represented in magenta (do-
main) and green (peptide). Some selected residues are labeled. Resi-
due numbers are maintained as in the reference (Shaw et al., 2005). L6
corresponds to L401 in the full protein sequence. In the peptide, the
conversion is such that E20 corresponds to E55.
(B) Lowest-energy structure of the complex with the domain shown as
a solid surface representation (in gold) and with the same orientation as
above. The peptide is shown by blue lines. Residues located in the
binding site as well as both tyrosine and proline binding grooves are
labeled. The green circle displays additional contacts observed in
the complex.
(C) Surface electrostatic representation of the complex rotated by 90
around the x axis with respect to the orientation shown in (B). The left
green circle displays the electrostatic complementation observed be-
tween the aspartic acid D90 in the peptide and both H25 and R13 in the
domain. This interaction is supported by NOEs from the peptide to the
domain. The right circle displays the potential contacts between argi-
nine 19 in the domain and E20 in the peptide.ights reserved
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Biological Relevance of WW Domain PhosphorylationTable 1. Statistics of ItchWW3 Domain NMR Structures Analyzed with PROCHECK
Restraints Used for the Calculation <SA>a
Intraresidual 244 protein, 29 peptide Intermolecular 47
Sequential (ji  jj = 1) 68 Unambiguous All
Medium-range (1 < ji  jj% 4) 23 Ambiguous 0
Long-range (ji  jj > 4) 79 Dihedrals 72
All 438 Hydrogen bonds 23
Rmsd (A˚) from Experimentalb Deviation from Idealized Covalent Geometry
NOE 0.01457 ± 0.00147 Angles () 1.2 ± 0.0775
Bonds (A˚) 0.00918 ± 5 3 104 Dihedral 0.73 ± 0.1
Coordinate Precision of the Complex (A˚)c
Backbone secondary-structure elements 0.33
Heavy atoms in secondary-structure elements 0.95
Heavy atoms all residues 1.64
Structural Quality
Total energyd 855 (± 75)
Electrostatic 1812 (± 49)
van der Waals 339 (± 36)
Bonds 21 (± 2.5)
Angles 137 (± 8.1)
Residues in most favored region
of Ramachandran plot (%)
86.1
Residues in additionally allowed region (%) 13.9
a <SA> refers to the ensemble of the ten structures with the lowest energy.
b No distance restraint in any of the structures included in the ensemble was violated by more than 0.3 A˚.
c Rmsd between the ensemble of structures <SA> and the lowest-energy structure.
d EL-J is the Lennard-Jones van der Waals energy calculated using CHARMM-PARMALLH6 parameters (Nilges et al., 1997).
EL-J was not included in the target function during structure calculation.were observed for its side chain, indicative of changes in
the proton chemical environment with respect to the free
state. A remarkable feature of this WW domain is that
R19 is unusually rigid. Indeed, not only is the N3H visible
but also both Hh1 and Hh21 protons are detected in the
NOESY experiments. Furthermore, upon addition of the li-
gand, the Hh protons change their chemical shifts. The
changes we observe in the pattern of NOEs of R19 proba-
bly occur due to side-chain rearrangement to facilitate li-
gand binding. In the free domain, the b and d protons of
R19 show NOEs to the Hz3 and Hh2 W32 protons. Interest-
ingly, these NOEs are weaker in the complex than in the
free domain, and the set of NOEs to the Y21 aromatic
ring gains intensity. In fact, in many of the calculated struc-
tures, the R19 side chain is sandwiched by electrostatic
interactions between D15 (in the domain) and E20 (in the
ligand) (Figures 3B and 3C).
Phosphorylation of the Ligand Does Not Prevent
ItchWW3 Binding
LMP2A is known to be subject to phosphorylation (Ingham
et al., 2005; Longnecker et al., 2000). Furthermore, muta-Structure 15, 4tion of both PPPY sequences to PPPA or deletion of the
motif reduced or abolished binding of LMP2A to ItchWW
domains (Ingham et al., 2005; Winberg et al., 2000).
Hence, we hypothesized that the phosphorylation of these
tyrosines might have an effect on the domain-ligand inter-
action. To test this hypothesis, three tyrosine-phosphory-
lated peptides (PY1phosYa, PY1phosYb [this tyrosine is
phosphorylated in cells], and PY2phosY) were synthe-
sized (Figure 1D). Due to the fact that the residue following
the PPxY in the second LMP2A motif is a serine, poten-
tially phosphorylatable, we also synthesized PY2phosS.
Residues displaying chemical-shift changes in the domain
upon binding to either PY1phosYa or PY1phosYb pep-
tides are similar with respect to the changes observed
for the unmodified PY (Figure 4A). However, whereas the
binding of the unphosphorylated PY and PY1phosYb
peptides is saturated at a ratio of approximately 1:3
protein:peptide, in the case of PY1phosYa, chemical-shift
changes continue to be observed at a 7-fold excess of
peptide, indicating a decrease in binding affinity. Further-
more, the interaction of ItchWW3 with PY1phosYa in-
duces significant changes in the H25 amide and R28 H373–483, April 2007 ª2007 Elsevier Ltd All rights reserved 477
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Biological Relevance of WW Domain PhosphorylationFigure 4. Titration Experiments for the Phosphorylated
Ligand Variants
(A) Bar representation showing the average chemical-shift changes
observed for the amide domain residues upon addition of the peptides
PY (brown), PY1phosYa (green), and PY1phosYb (yellow) with respect
to the free domain. PY was measured at a ratio of 1:2.5 domain:ligand;
PY1phosYa and PY1phosYb were measured at ratios of 1:7 and 1:2.5,
respectively. The inset corresponds to the HSQC region displaying the
N3H peaks of arginines (nitrogen chemical shift is folded). Black signals
correspond to the reference spectrum. The final point of the PY titra-
tion is plotted in brown, PY1phosYa titration is shown in green, and
PY1phosYb is shown in yellow. Although the addition of peptide PY in-
duces changes mainly in R19 (on the left), the presence of a tyrosine
phosphorylated in PY1phosYa also affects the resonance of R28.
(B) Amide changes observed upon addition of peptides PY2phosY
(green) and PY2phosS (orange) corresponding to the second PPxY
motif present in LMP2A. Changes induced by PY are plotted as a refer-
ence. Changes were not followed to saturation. The inset corresponds
to the HSQC region displaying the N3H peaks of arginines as in (A). Ty-
rosine phosphorylation of the second PPxY motif present in LMP2A
also induces changes in R28, but in this case the changes observed
in R19 are smaller than those observed for the PY and PY1phosYa
peptides. We attribute these differences to the absence of negatively
charged residues preceding the PPxY motif in both PY2phosS and
PY2phosY peptides.
(C) Model based on the minimum-energy structure of ItchWW3 in com-
plex with PY peptide, showing that the phosphotyrosine in the PPxY
motif can be accommodated in the complex.478 Structure 15, 473–483, April 2007 ª2007 Elsevier Ltd All rigchemical shifts. The R28 H3 change is particularly large
compared to the titrations with PY (Figure 4A, insets).
The three-dimensional structure of the complex of
ItchWW3 with PY confirms the location of R28 at the start
of the third b strand, and the arginine’s long positively
charged side chain is a likely candidate to accommodate
the negative phosphate group of the bound phosphotyro-
sine through electrostatic interactions. PY2phosY binds to
the ItchWW3 domain in a similar manner as PY1phosYa.
In the case of PY2phosY, the titration was not continued
to saturation, but chemical-shift changes were clearly
noticeable at a protein:peptide ratio of 1:4.5 (Figure 4B).
Figure 4C displays a model generated from the minimum-
energy structure of the ItchWW3-PY complex, where PY1-
phosYa substitutes for the PY peptide. In the PY complex,
R28 side-chain orientation is not fully fixed, as shown in
Figure 3A. According to the model, for the phosphotyro-
sine to fit into the tyrosine cavity, R28 needs to adopt
the conformations in which an increase in cavity size oc-
curs. A similar effect may also occur at the ligand level:
some of the possible tyrosine orientations used to fit into
the tyrosine groove could be sterically unavailable to the
phosphotyrosine. The restrictions in the rotational free-
dom introduced by binding to a phosphorylated ligand
do not seem to be fully compensated by the potential elec-
trostatic interaction with the arginine 28 side chain, result-
ing in the observed decrease in affinity. Interestingly, if
phosphorylation is as in PY2phosS (in the C-terminal re-
gion of the PPxY motif), binding occurs as in the reference
peptide PY (Figure 4C). We thus conclude that in ItchWW-
PPxY interactions, tyrosine phosphorylation of the motif
does not prevent complex formation, but clearly inhibits
the interaction.
Phosphorylation of ItchWW3 at T30 Inhibits
Intermolecular Interactions
In Shaw et al. (2005), we showed that phosphorylation of
ItchWW3 at either S16 or T30 does not disrupt domain
structure. Therefore, any potential effect of phosphoryla-
tion on ligand binding cannot be attributed to domain
misfolding. To ensure that all molecules are fully phos-
phorylated at exclusively the desired positions, phosphor-
ylated ItchWW3 samples were synthesized. Accordingly,
these unlabeled samples forced us to use experiments
such as 1H-1H 2D TOCSY to monitor the chemical-shift
perturbation. Figure 5A shows how the spectrum of
pT30-ItchWW3 in the presence of 7-fold excess PY ligand
(magenta) compares to the free domain (black). In it, there
are no apparent proton chemical-shift changes. Additional
peaks correspond only to the free peptide. This result is in
sharp contrast to the changes induced when PY peptide
binds the unphosphorylated ItchWW3 domain, shown
earlier in Figures 2A and 2B. Phosphorylation of T30
thus appears to abolish PY binding. The same experi-
ments were measured for pS16-ItchWW3 (see Figure S1
in the Supplemental Data available with this article online).
In contrast to the pT30-ItchWW3 sample, phosphorylation
of S16 does not inhibit binding to the PY peptide and the
pattern of changes resembles that observed for thehts reserved
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Biological Relevance of WW Domain PhosphorylationFigure 5. Titration Experiments for the Phosphorylated Domain Variants and Phosphorylation of ItchWW Domains
(A) Superimposition of pT30 (phosphorylated T30) TOCSY spectrum in the free state (black) and after the addition of a 7-fold excess of PY peptide
(magenta). Selected residues located in the domain’s binding site are labeled. Even in the presence of a high excess of peptide, no changes in the
domain’s resonances are observed.
(B) Surface and cartoon representation of the structures of the ItchWW3 domain (in blue).
(C) Surface and cartoon representation of the structures of pT30 (in yellow) showing that the phosphorylation of T30 partially reduces the XP binding
groove, used to interact with the ligand prolines.
(D) Left: WW3 phosphorylation in T lymphocytes. Overexpressed WW3 domain, S16A, and double S16A/T30A variants were incubated with T lym-
phocyte extracts. Upon activation with CD33-CD28, both wild-type domain and the S16A variant are phosphorylated, whereas no phosphorylation is
observed in the double mutant S16A/T30A. This suggests that T30 is phosphorylated in activated T lymphocytes. Right: corresponding Coomassie-
stained gel.
(E) Left: in vitro phosphorylation of ItchWW domains. Wild-type WW3 and T30A variants were incubated with CK2 in the absence or presence of sper-
mine, an activator of CK2 kinase. The wild-type domain is phosphorylated in both conditions, while the variant T30A remains unphosphorylated. PKA
phosphorylates both WW3 and WW4 domains. In the case of WW4, there is only one possible PKA phosphorylation site, that of T30; however, WW3
contains two, S16 and T30. Under our experimental conditions, both wild-type and the T30A variants are efficiently phosphorylated whereas S16A is
not, suggesting that only position S16 is a target for PKA in vitro.unphosphorylated ItchWW3. This result is compatible with
the structure of the ItchWW3-PY complex, where it can be
observed that S16 does not contribute to ligand binding
and, in addition, is located in the first loop, with enough
room to fit a phosphate group without disturbing the
neighboring side chains.Structure 15, 4The pT30 Structure
As we showed that domain unfolding could not be the rea-
son for the observed binding inhibition, we used the pub-
lished assignment data corresponding to the pT30 variant
(from Shaw et al., 2005) to generate a family of structures
for this variant. These structures show that pT30 is73–483, April 2007 ª2007 Elsevier Ltd All rights reserved 479
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nine in the wild-type structure. Indeed, in both cases,
the methyl shows the same pattern of NOEs to the Y21
and V23 side chains. However, in the pT30 variant, there
is a size increase of the threonine upon phosphorylation
of its hydroxyl group. Also, the phosphate group cannot
contribute to ligand interaction by means of hydrogen
bonding. Thus, the observed inhibition of binding is prob-
ably a consequence of both steric hindrance and the im-
possibility of forming a hydrogen bond with the ligand.
A surface and cartoon representation of both wild-type
and pT30 mutant structures are shown in Figures 5B
and 5C.
Phosphorylation of the ItchWW3 Domain in
T Lymphocytes and with CK2 and PKA Kinases
In our analysis of ItchWW domains in Shaw et al. (2005),
the NetPhosK 2.0 (Blom et al., 1999) phosphorylation
site prediction program found four sites located in the
WW3 domain: S16, Y19, T29, and T30. Position T30 was
predicted with the highest score and was a hit in three of
the four ItchWW domains. Site S16 was also predicted
with high reliability, and phosphorylation of an equivalent
area is known in the Pin1WW domains. T30-WW3 was
predicted to be phosphorylated by at least two kinases,
casein kinase II (CK2) and protein kinase A (PKA), while
S16-WW3 and T30-WW4 were predicted to be phosphor-
ylated by PKA (sites described for the kinases are xS/
TxxD/E and Rx1-2S/Tx, respectively). The remaining pair
of predicted positions was not studied further. The T29
site was discarded on the basis of its side chain pointing
toward the domain core and thus not being accessible
to kinases, whereas Y19 was discarded because it was
not a hit in the tyrosine phosphorylation assay of Yang
et al. (2006).
To facilitate the identification of the phosphorylation
sites in the experiments in vitro, we prepared mutants of
ItchWW3 where positions suitable for phosphorylation
were mutated to alanine (S16A, T30A, and S16A/T30A).
The typical pattern of NOEs that defines the triple-
stranded antiparallel b sheet was detected for the three
alanine variants, corroborating that the mutations do not
affect the structure (NMR data not shown). For the phos-
phorylation assays, we incubated the purified domains
with either T lymphocyte lysates (untreated or stimulated
with anti-CD3 and anti-CD28 antibodies) or directly with
the two predicted kinases, CK2 and PKA.
T lymphocyte lysates incubated with purified ItchWW3,
S16A, or S16A/T30A in the presence of g-labeled ATP
showed that the WW3 and S16A variant domains could
be detected by autoradiography, whereas the S16A/
T30A variant was not. The fact that the S16A mutant and
the wild-type samples are phosphorylated but the double
mutant S16A/T30A is not indicates that among the pre-
dicted sites, T30 is the most accessible to kinases present
in the lysates. We thus conclude that under our experi-
mental conditions, the third WW domain can be phos-
phorylated at position T30 (Figure 5D).480 Structure 15, 473–483, April 2007 ª2007 Elsevier Ltd All rIn the second set of experiments, we used three purified
ItchWW domain constructs (WW1-2, WW3, and WW4)
and the T30A and S16A-WW3 variants together with the
serine/threonine kinases CK2 and PKA (Figure 5E). Our re-
sults show that with CK2, only the third domain is effi-
ciently phosphorylated in the presence and/or absence
of an activator such as spermine (Leroy et al., 1997). The
WW1-2 and WW4 constructs were unaffected (data not
shown). With PKA, however, two domains, WW3 and
WW4, are efficiently phosphorylated. Remarkably, the
T30A-WW3 variant is also phosphorylated by PKA but
not the S16A variant, indicating that this kinase only phos-
phorylates at the S16 position. From these experiments,
we conclude that position T30 is accessible to kinases,
to CK2 in the case of WW3 and to PKA in the case of WW4.
DISCUSSION
Whereas the sequence of WW domains is quite conserved
among the different Nedd4 ligases, the contrary occurs
with respect to the ligands, as they only share the PPxY
motif. To better understand how Nedd4 E3 ligases recog-
nize their ligands, we investigated the interactions be-
tween the mouse ItchWW3 domain and PPxY motifs
from the Epstein-Barr viral protein LMP2A using NMR
spectroscopy.
The fact that ItchWW3 mainly requires the PPxY motif
for ligand binding may explain the large number of candi-
dates that it can recognize. Herein lies the main difference
between this structure and that of the E3 ubiquitin ligase
Nedd4WW domain in complex with either the epithelial
sodium channel bP2 peptide (Kanelis et al., 2001) or the
Comm PY peptide (Kanelis et al., 2006) or between
Smad7 and the WW3 domain of the E3 ubiquitin ligase
Smurf2 (Chong et al., 2006). In the first and last com-
plexes, the C-terminal part of the peptide after the PPxY
motif is structured and involved in crucial contacts to res-
idues located in the first strand of the domain. In the sec-
ond case, both termini are involved in the interaction and
contacts from residues located in the first loop of the do-
main were also identified. The high number of contacts
probably results in the high affinity of this particular
complex, which is one of the highest measured for WW
complexes (3 mM instead of 50 mM for the ItchWW3-
PY complex described here).
Because target recognition is the first step toward pro-
tein polyubiquitination and degradation, we were inter-
ested in clarifying how the domain-ligand interaction can
be regulated, a question not yet understood in the field
of WW domain interactions. We aimed to investigate the
potential role of phosphorylation directly at the interface
of binding, looking from both domain and ligand perspec-
tives. We found that phosphorylation of LMP2A peptides
at the PPxY motif decreases the affinity of the interaction
although it does not abolish it, indicating that the ItchWW3
binding site is able to accommodate the tyrosine’s phos-
phate group but with greater difficulty than the unmodified
tyrosine. The reduction in affinity, however, can play
an important biological role, as, depending on the globalights reserved
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old at the noise level. In this sense, it has recently been ob-
served that phosphorylation of the PPxY motif of cJun is
enough to prevent its efficient degradation in T lympho-
cytes (Gao et al., 2006).
In contrast to phosphorylation of the ligand, phosphor-
ylation of residue T30 in the domain was found to fully
inhibit binding to the PY peptide. The phosphorylation
experiments with T lymphocyte lysates and with purified
kinases show that T30 can be phosphorylated in vitro,
supporting the hypothesis that domain phosphorylation
may also occur in intact cells. In fact, phosphorylation of
a serine in the first loop of the prolyl-isomerase Pin1WW
domain (named S16, which is in a position equivalent to
that of D15 in the ItchWW3 sequence) has also been ob-
served in cells and has a similar role in binding inhibition
(Lu et al., 2002). The Pin1WW domain belongs to group
4 of WW domains, a group specialized in the interaction
with phosphorylated ligands. Interestingly, S16 is not con-
served in the WW family of sequences, and its phosphor-
ylation seems to be highly specific for Pin1WW domains.
T30, on the contrary, is highly conserved in the WW do-
main family, with about 90% of all WW domains known
to date displaying a hydroxyl-containing residue at this
position in the sequence. It has been previously shown
for the Yap65WW domain—another member of group
1—that mutation of position 30 to all 20 possible amino
acids has a dramatic influence on binding (Toepert et al.,
2001). Indeed, only three amino acids are permitted at
this position: threonine (wild-type residue), serine, and
phenylalanine. The significance of the phenylalanine mu-
tation is not explained by the hydroxyl theory, but the affin-
ity shown is severely reduced and may involve a different
set of interactions. All remaining substitutions cancel li-
gand binding, indicating a potential role for the hydroxyl
group in the interaction. Furthermore, from the 11 WW do-
main complexes present in the Protein Data Bank, in
seven cases the residue at position 30 (serine or threonine
in all complexes so far) participates in contacts to the li-
gand, often showing an appropriate geometry to form a hy-
drogen bond to the ligand. Of these seven complexes, six
belong to group 1 and one to group 2 (Huang et al., 2000;
Kanelis et al., 2006; Pires et al., 2001, 2005). This too is ob-
served in the ItchWW3-LMP2A PY complex. The structure
of the pT30 variant described here rationalizes that the
presence of the phosphate induces some steric hindrance
and prevents the formation of the hydrogen bond to the
second proline in the PPxY motif, contributing to the
destabilization and regulation of the ligand interaction
(Figures 5B and 5C).
It is known that in monoubiquitination processes, Itch
ubiquitination is a prerequisite to achieving the monoubi-
quitination reaction (Woelk et al., 2006). However, how
the target-recognition process is controlled in polyubiqui-
tination cascades remains elusive. It is clear that proteins
need time to act before their degradation and, obviously,
degradation is required to prevent protein accumulation.
It has recently been suggested that Itch phosphorylation
by JNK1 in T lymphocytes modulates its intramolecular in-Structure 15,teractions. After JNK1 activation, Itch suffers a profound
conformational rearrangement, shifting from the ‘‘closed
conformation,’’ where the WW domains directly contact
the catalytic HECT domain, to the ‘‘open conformation.’’
In this conformation, ItchWW domains are able to interact
with other proteins and contribute to their ubiquitination
and degradation (Gallagher et al., 2006). Alternatively,
the WW domains can be modified by kinases and stop
their interactions. Our results suggest that while the WW
domain is phosphorylated in a key residue for ligand rec-
ognition such as T30, ligands would not be efficiently rec-
ognized and targets could prevent their degradation.
Thus, the initial change in conformation described in Itch
after JNK1 activation could be the first step of a cascade
of events that may include a WW domain phosphorylation/
dephosphorylation equilibrium, providing a mechanism of
target survival through inhibition of degradation. Further
studies in vivo on whether phosphorylation can occur in
these ancillary domains may prove key to the understand-




The pETM-30 vector was used for all expression constructs. All
ItchWW domains were prepared essentially as described (Shaw
et al., 2005). NMR samples corresponding to ItchWW3 had a concen-
tration of 1.0 mM (triple-resonance experiments) or 0.2 mM (titration
experiments) and were dissolved in 50 mM sodium phosphate buffer,
100 mM NaCl, 0.02% (w/v) NaN3 in 90% H2O/10% D2O or 100% D2O
(pH 6.0–7.2).
Site-Directed Mutagenesis
Mutation of Thr30 and Ser16 to alanine in the WW3 domain was per-
formed using the Stratagene QuikChange Site-Directed Mutagenesis
Kit. All sequences were confirmed by DNA sequencing and the purified
proteins by mass spectrometry.
Peptide Synthesis
The peptides shown in Figure 1D were synthesized and purified as
described (Shaw et al., 2005).
Isothermal Titration Calorimetry
ITC experiments were performed using the Microcal equipment at the
European Molecular Biology Laboratory, Heidelberg, Germany. Pro-
tein and peptide samples were centrifuged and degassed before use
and all experiments were performed at 25C. The cell chamber
contained 2.3 ml of 50 mM protein into which a 103 concentration of
peptide was injected. Both components were prepared in 100 mM
NaCl, 50 mM sodium phosphate (pH 6.0). The data were analyzed
with Mircocal’s Origin software, using a binding model that assumes
a single site of interaction.
ItchWW3 Binding-Site Mapping
Chemical-shift perturbation experiments with 15N-labeled and unla-
beled peptides were performed at 600 MHz proton frequency on a
Bruker DRX-600 NMR spectrometer at 285K using 2D 1H,15N HSQC
spectra. A reference 1H,15N HSQC experiment of the protein was mea-
sured before stepwise addition of peptides. The ligand solution in each
case was 1003 the concentration of ItchWW3. 1H,15N HSQC spectra
were measured after each addition. The data were processed using
the XWinNMR software that accompanies the spectrometer and
were analyzed using XEASY/CARA packages.473–483, April 2007 ª2007 Elsevier Ltd All rights reserved 481
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NMR experiments were carried out at 285K on Bruker DRX-600 and
DRX-800 NMR spectrometers equipped with triple-resonance Z gradi-
ent probes. Standard triple-resonance experiments were used to as-
sign the backbone and aliphatic side-chain atoms of the protein, while
aromatic protons were obtained from 2D homonuclear TOCSY and
NOESY. The PY peptide in both free and bound forms was assigned
combining the information from homonuclear 2D TOCSY and NOESY
experiments with that of 2D 13C-filtered NOESY and 13C-edited
NOESY spectra (Sattler et al., 1999; Wu¨thrich, 1986 and references
therein). Inter- and intramolecular proton distance restraints were ob-
tained from fully assigned peaks from a 2D NOESY experiment mea-
sured in D2O and from 3D
15N- and 13C-edited NOESY experiments
using mixing times of 140 and 160 ms. For the pT30 variant (0.8 mM
sample dissolved in the same buffer as the wild-type), two NOESYs
were run at 280K and 285K and mixing times of 160 ms were used.
NOESY spectra were integrated with the XEASY package using the
maximum option (Bartels et al., 1995). All data were processed using
NMRPipe/NMRDraw (Delaglio et al., 1995) and analyzed with CARA.
Manually and unambiguously assigned peaks and only experimentally
obtained 3J(HN,Ha) coupling constants, stereospecific assignments,
and hydrogen-bond restraints were used during the calculation. The
structures were calculated using CNS (Bru¨nger et al., 1998) with an
in-house modified protocol of Aria1.2 (Nilges et al., 1997). The protocol
calculated a set of 100 structures, with 100,000 cooling steps. All 100
structures were submitted to water refinement. We also modified the
water-refinement protocol by weighing the value of hydrogen bonds,
unambiguous NOEs, and dihedral restraints by a factor of 10. In this
way, all experimental restraints are used during the refinement process
and we thus obtain structures in better agreement with our data—while
retaining good Ramachandran values—than when using the original
water-refinement protocol provided with Aria1.2. Modified protocols
are provided upon request. The quality of the final ten best structures
was evaluated using the program PROCHECK-NMR (Laskowski et al.,
1996), and the statistics obtained from the analysis are shown in
Table 1.
Phosphorylation of ItchWW Domains with EL4 T-Lysated Cells
Ten micrograms of mouse EL4 T eukaryotic cells was left untreated or
stimulated with anti-CD33 (10 mg/ml) and anti-CD28 (1 mg/ml) anti-
bodies. Lysates were then incubated with 100 mM ATP, 0.1 ml of
[g-32P]ATP (stock solution is 10 mci/ml), and 0.5–1 mg of each protein
substrate in a final volume of 27 ml of reaction adjusted with 20 mM
HEPES Na (pH 7.5), 20 mM b-glycerophosphate, 20 mM MgCl2,
1.1 mM sodium orthovanadate, 2 mM dithiothreitol (DTT) buffer for
1 hr.
In Vitro Phosphorylation of ItchWW Domains
CK2 and PKA were purchased from New England Biolabs. PKA was
used as recommended by the manufacturer, while in the case of
CK2, we incubated 1 ml of CK2 (500 units) with 4 ml of 150 mM NaCl,
50 mM Tris HCl (pH 8.0) buffer in the presence of 0.1% BSA at 30C
for 30 min. After this step, we added the substrate (10 ml of PBS con-
taining 5 mg of protein) and the phosphorylation buffer (5 ml of 26.6 mM
MgCl2, 3.33 mM DTT, 20 mM ATP per 0.1 ml of [g-
32P]ATP; stock solu-
tion is 10 mci/ml). The mixture was left at 30C overnight. When spermi-
dine was used as an activator of the kinase reaction, it was added to
the buffer reaction prior to the overnight incubation (final concentration
of 10 mM).
Phosphorylation Detection
Phosphorylation reactions were interrupted by addition of SDS sample
buffer and subjected to SDS-PAGE. 32P was detected by autoradiog-
raphy and with a phosphoimager screen.
Supplemental Data
Supplemental Data include one figure and can be found with this article
online at http://www.structure.org/cgi/content/full/15/4/473/DC1/.482 Structure 15, 473–483, April 2007 ª2007 Elsevier Ltd AllACKNOWLEDGMENTS
We are grateful to G. Stier for experimental advice and the gift of the
expression vector and the His-tagged TEV protease, to Lars Gredsted,
European Molecular Biology Laboratory, Heidelberg, for the gift of the
mouse pituitary cDNA library, to Anna Messeguer for advice regarding
in vitro phosphorylation assays with CK2, and to the NMR service of
the University of Barcelona for measurement time. A.Z.S., B.M.,
P.M.-M., X.R.-E., and F.Y. acknowledge the IRB for predoctoral fellow-
ships. A.Z.S., X.R.-E., and M.J.M. also acknowledge the EMBL for
support. This work was financed by grants GEN2003-20642-C09-04
and BFU2005-06276 (M.J.M.), BFU2004-05725/BMC (A.C.), and
CTQ2005-0315 (M.R.) by Spanish Ministerio de Educacio´n y Ciencia.
Conflicts of interest: all authors declare the absence of commercial
interests related to this work.
Received: November 29, 2006
Revised: March 8, 2007
Accepted: March 14, 2007
Published: April 17, 2007
REFERENCES
Bartels, C., Xia, T.-H., Billeter, M., Gu¨ntert, P., and Wu¨thrich, K. (1995).
The program XEASY for computer-supported NMR spectral analysis
of biological macromolecules. J. Biomol. NMR 5, 1–10.
Blom, N., Gammeltoft, S., and Brunak, S. (1999). Sequence and struc-
ture-based prediction of eukaryotic protein phosphorylation sites.
J. Mol. Biol. 294, 1351–1362.
Bork, P., and Sudol, M. (1994). The WW domain: a signalling site in
dystrophin? Trends Biochem. Sci. 19, 531–533.
Bru¨nger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,
Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu,
N.S., et al. (1998). Crystallography and NMR system: a new software
suite for macromolecular structure determination. Acta Crystallogr.
D Biol. Crystallogr. 54, 905–921.
Chen, H.I., and Sudol, M. (1995). The WW domain of Yes-associated
protein binds a proline-rich ligand that differs from the consensus es-
tablished for Src homology 3-binding modules. Proc. Natl. Acad. Sci.
USA 92, 7819–7823.
Chong, P.A., Lin, H., Wrana, J.L., and Forman-Kay, J.D. (2006). An ex-
panded WW domain recognition motif revealed by the interaction be-
tween Smad7 and the E3 ubiquitin ligase Smurf2. J. Biol. Chem. 281,
17069–17075.
Courbard, J.R., Fiore, F., Adelaide, J., Borg, J.P., Birnbaum, D., and
Ollendorff, V. (2002). Interaction between two ubiquitin-protein isopep-
tide ligases of different classes, CBLC and AIP4/ITCH. J. Biol. Chem.
277, 45267–45275.
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A.
(1995). NMRPipe: a multidimensional spectral processing system
based on UNIX pipes. J. Biomol. NMR 6, 277–293.
Fang, D., and Kerppola, T.K. (2004). Ubiquitin-mediated fluorescence
complementation reveals that Jun ubiquitinated by Itch/AIP4 is local-
ized to lysosomes. Proc. Natl. Acad. Sci. USA 101, 14782–14787.
Fang, D., Elly, C., Gao, B., Fang, N., Altman, Y., Joazeiro, C., Hunter,
T., Copeland, N., Jenkins, N., and Liu, Y.C. (2002). Dysregulation of
T lymphocyte function in itchy mice: a role for Itch in TH2 differentia-
tion. Nat. Immunol. 3, 281–287.
Fruehling, S., Swart, R., Dolwick, K.M., Kremmer, E., and Longnecker,
R. (1998). Tyrosine 112 of latent membrane protein 2A is essential for
protein tyrosine kinase loading and regulation of Epstein-Barr virus
latency. J. Virol. 72, 7796–7806.
Gallagher, E., Gao, M., Liu, Y.C., and Karin, M. (2006). Activation of the
E3 ubiquitin ligase Itch through a phosphorylation-induced conforma-
tional change. Proc. Natl. Acad. Sci. USA 103, 1717–1722.rights reserved
Structure
Biological Relevance of WW Domain PhosphorylationGao, M., Labuda, T., Xia, Y., Gallagher, E., Fang, D., Liu, Y.C., and
Karin, M. (2004). Jun turnover is controlled through JNK-dependent
phosphorylation of the E3 ligase Itch. Science 306, 271–275.
Gao, B., Lee, S.M., and Fang, D. (2006). The tyrosine kinase c-Abl
protects c-Jun from ubiquitination-mediated degradation in T cells.
J. Biol. Chem. 281, 29711–29718.
Hershko, A., Ciechanover, A., and Varshavsky, A. (2000). Basic Medi-
cal Research Award. The ubiquitin system. Nat. Med. 6, 1073–1081.
Huang, X., Poy, F., Zhang, R., Joachimiak, A., Sudol, M., and Eck, M.J.
(2000). Structure of a WW domain containing fragment of dystrophin in
complex with b-dystroglycan. Nat. Struct. Biol. 7, 634–638.
Hustad, C.M., Perry, W.L., Siracusa, L.D., Rasberry, C., Cobb, L., Cat-
tanach, B.M., Kovatch, R., Copeland, N.G., and Jenkins, N.A. (1995).
Molecular genetic characterization of six recessive viable alleles of
the mouse agouti locus. Genetics 140, 255–265.
Ikeda, M., Ikeda, A., Longan, L.C., and Longnecker, R. (2000). The
Epstein-Barr virus latent membrane protein 2A PY motif recruits WW
domain-containing ubiquitin-protein ligases. Virology 268, 178–191.
Ingham, R.J., Gish, G., and Pawson, T. (2004). The Nedd4 family of E3
ubiquitin ligases: functional diversity within a common modular archi-
tecture. Oncogene 23, 1972–1984.
Ingham, R.J., Raaijmakers, J., Lim, C.S., Mbamalu, G., Gish, G., Chen,
F., Matskova, L., Ernberg, I., Winberg, G., and Pawson, T. (2005). The
Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine
kinases used by the T cell receptor. J. Biol. Chem. 280, 34133–34142.
Kanelis, V., Rotin, D., and Forman-Kay, J.D. (2001). Solution structure of
aNedd4WWdomain-ENaCpeptidecomplex.Nat.Struct.Biol.8, 407–412.
Kanelis, V., Bruce, M.C., Skrynnikov, N.R., Rotin, D., and Forman-Kay,
J.D. (2006). Structural determinants for high-affinity binding in a Nedd4
WW3* domain-Comm PY motif complex. Structure 14, 543–553.
Laskowski, R.A., Rullmann, J.A., MacArthur, M.W., Kaptein, R., and
Thornton, J.M. (1996). AQUA and PROCHECK-NMR: programs for
checking the quality of protein structures solved by NMR. J. Biomol.
NMR 8, 477–486.
Leroy, D., Filhol, O., Delcros, J.G., Pares, S., Chambaz, E.M., and
Cochet, C. (1997). Chemical features of the protein kinase CK2 poly-
amine binding site. Biochemistry 36, 1242–1250.
Longnecker, R., Merchant, M., Brown, M.E., Fruehling, S., Bickford,
J.O., Ikeda, M., and Harty, R.N. (2000). WW- and SH3-domain interac-
tions with Epstein-Barr virus LMP2A. Exp. Cell Res. 257, 332–340.
Lu, P.J., Zhou, X.Z., Liou, Y.C., Noel, J.P., and Lu, K.P. (2002). Critical
role of WW domain phosphorylation in regulating phosphoserine bind-
ing activity and Pin1 function. J. Biol. Chem. 277, 2381–2384.
Macias, M.J., Hyvonen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste,
M., and Oschkinat, H. (1996). Structure of the WW domain of a kinase-
associated protein complexed with a proline-rich peptide. Nature 382,
646–649.
Macias, M.J., Wiesner, S., and Sudol, M. (2002). WW and SH3 do-
mains, two different scaffolds to recognize proline-rich ligands.
FEBS Lett. 513, 30–37.
Magnifico, A., Ettenberg, S., Yang, C., Mariano, J., Tiwari, S., Fang, S.,
Lipkowitz, S., and Weissman, A.M. (2003). WW domain HECT E3s tar-
get Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem.
278, 43169–43177.
Myers, J.K., Morris, D.P., Greenleaf, A.L., and Oas, T.G. (2001). Phos-
phorylation of RNA polymerase II CTD fragments results in tight bind-
ing to the WW domain from the yeast prolyl isomerase Ess1. Biochem-
istry 40, 8479–8486.
Nilges, M., Macias, M.J., O’Donoghue, S.I., and Oschkinat, H. (1997).
Automated NOESY interpretation with ambiguous distance restraints:
the refined NMR solution structure of the pleckstrin homology domain
from b-spectrin. J. Mol. Biol. 269, 408–422.
Park, S.J., Seo, M.D., Lee, S.K., Ikeda, M., Longnecker, R., and Lee,
B.J. (2005). Expression and characterization of N-terminal domain ofStructure 15,Epstein-Barr virus latent membrane protein 2A in Escherichia coli.
Protein Expr. Purif. 41, 9–17.
Perry, W.L., Hustad, C.M., Swing, D.A., O’Sullivan, T.N., Jenkins, N.A.,
and Copeland, N.G. (1998). The itchy locus encodes a novel ubiquitin
protein ligase that is disrupted in a18H mice. Nat. Genet. 18, 143–146.
Pires, J.R., Taha-Nejad, F., Toepert, F., Ast, T., Hoffmuller, U.,
Schneider-Mergener, J., Kuhne, R., Macias, M.J., and Oschkinat, H.
(2001). Solution structures of the YAP65 WW domain and the variant
L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY
and PLPPY and the application of peptide libraries reveal a minimal
binding epitope. J. Mol. Biol. 314, 1147–1156.
Pires, J.R., Parthier, C., Aido-Machado, R., Wiedemann, U., Otte, L.,
Bohm, G., Rudolph, R., and Oschkinat, H. (2005). Structural basis for
APPTPPPLPP peptide recognition by the FBP11WW1 domain.
J. Mol. Biol. 348, 399–408.
Rossi, M., De Laurenzi, V., Munarriz, E., Green, D.R., Liu, Y.C., Vous-
den, K.H., Cesareni, G., and Melino, G. (2005). The ubiquitin-protein
ligase Itch regulates p73 stability. EMBO J. 24, 836–848.
Sattler, M., Schleucher, J., and Griesinger, C. (1999). Heteronuclear
multidimensional NMR experiments for the structure determination
of proteins in solution employing pulsed field gradients. Prog. Nucl.
Magn. Reson. Spectrosc. 34, 93–158.
Shaw, A.Z., Martin-Malpartida, P., Morales, B., Yraola, F., Royo, M.,
and Macias, M.J. (2005). Phosphorylation of either Ser16 or Thr30
does not disrupt the structure of the Itch E3 ubiquitin ligase third
WW domain. Proteins 60, 558–560.
Shi, H., Asher, C., Chigaev, A., Yung, Y., Reuveny, E., Seger, R., and
Garty, H. (2002). Interactions of b and g ENaC with Nedd4 can be fa-
cilitated by an ERK-mediated phosphorylation. J. Biol. Chem. 277,
13539–13547.
Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., and
Rotin, D. (1996). WW domains of Nedd4 bind to the proline-rich PY
motifs in the epithelial Na+ channel deleted in Liddle’s syndrome.
EMBO J. 15, 2371–2380.
Toepert, F., Pires, J.R., Landgraf, C., Oschkinat, H., and Schneider-Mer-
gener, J. (2001). Synthesis of an array comprising 837 variants of the
hYAP WW protein domain. Angew. Chem. Int. Ed. Engl. 40, 897–900.
Traweger, A., Fang, D., Liu, Y.C., Stelzhammer, W., Krizbai, I.A.,
Fresser, F., Bauer, H.C., and Bauer, H. (2002). The tight junction-
specific protein occludin is a functional target of the E3 ubiquitin-
protein ligase Itch. J. Biol. Chem. 277, 10201–10208.
Verdecia, M.A., Bowman, M.E., Lu, K.P., Hunter, T., and Noel, J.P.
(2000). Structural basis for phosphoserine-proline recognition by
group IV WW domains. Nat. Struct. Biol. 7, 639–643.
Winberg, G., Matskova, L., Chen, F., Plant, P., Rotin, D., Gish, G.,
Ingham, R., Ernberg, I., and Pawson, T. (2000). Latent membrane pro-
tein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin
ligases that ubiquitinate B-cell tyrosine kinases. Mol. Cell. Biol. 20,
8526–8535.
Woelk, T., Oldrini, B., Maspero, E., Confalonieri, S., Cavallaro, E., Di
Fiore, P.P., and Polo, S. (2006). Molecular mechanisms of coupled
monoubiquitination. Nat. Cell Biol. 8, 1246–1254.
Wu¨thrich, K. (1986). NMR of Proteins and Nucleic Acids (New York:
John Wiley & Sons).
Yang, C., Zhou, W., Jeon, M.S., Demydenko, D., Harada, Y., Zhou, H.,
and Liu, Y.C. (2006). Negative regulation of the E3 ubiquitin ligase Itch
via Fyn-mediated tyrosine phosphorylation. Mol. Cell 21, 135–141.
Accession Numbers
The 1H, 15N, and 13C chemical-shift assignments for the complex and
the pT30WW variant have been deposited in the BioMagResBank
database under the accession numbers 15153 and 15159, respec-
tively, and the protein coordinates have been deposited in the Protein
Data Bank under ID codes 2jo9 (complex) and 2joc (pT30WW variant).473–483, April 2007 ª2007 Elsevier Ltd All rights reserved 483
